Motif ID: Hic1
Z-value: 2.088
Transcription factors associated with Hic1:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Hic1 | ENSMUSG00000043099.4 | Hic1 |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 6.9 | GO:0032430 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) positive regulation of phospholipase A2 activity(GO:0032430) activation of meiosis involved in egg activation(GO:0060466) |
1.5 | 5.9 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.4 | 4.3 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
1.3 | 5.2 | GO:0021564 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
1.2 | 3.7 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
1.2 | 4.9 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.2 | 6.9 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.1 | 3.4 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
1.1 | 2.3 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
1.1 | 4.5 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
1.0 | 3.0 | GO:0042560 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.9 | 0.9 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.9 | 3.6 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.9 | 15.4 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.8 | 2.5 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.8 | 2.5 | GO:0071317 | cellular response to isoquinoline alkaloid(GO:0071317) |
0.8 | 2.5 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
0.8 | 7.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.8 | 3.2 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.8 | 3.2 | GO:0009414 | response to water deprivation(GO:0009414) |
0.8 | 2.3 | GO:0099548 | drug catabolic process(GO:0042737) exogenous drug catabolic process(GO:0042738) retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by nitric oxide(GO:0099548) |
0.8 | 2.3 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.7 | 2.2 | GO:2000793 | cell proliferation involved in heart valve development(GO:2000793) |
0.7 | 5.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.7 | 2.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.7 | 2.9 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.7 | 2.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.7 | 2.8 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.7 | 2.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.7 | 2.7 | GO:0007412 | axon target recognition(GO:0007412) |
0.6 | 3.2 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.6 | 2.6 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.6 | 5.8 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.6 | 2.5 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
0.6 | 3.1 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.6 | 1.9 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.6 | 2.5 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.6 | 1.8 | GO:1904978 | regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
0.6 | 3.6 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.6 | 2.4 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.6 | 2.4 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.6 | 4.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.6 | 1.8 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.6 | 1.7 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
0.6 | 2.9 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.6 | 1.7 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.6 | 2.8 | GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
0.6 | 1.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.5 | 0.5 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.5 | 2.7 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.5 | 1.1 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.5 | 2.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.5 | 3.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.5 | 4.1 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.5 | 4.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.5 | 2.0 | GO:0021586 | pons maturation(GO:0021586) |
0.5 | 6.5 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.5 | 1.5 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.5 | 1.5 | GO:0035604 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
0.5 | 1.0 | GO:1902022 | L-lysine transport(GO:1902022) |
0.5 | 0.9 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.5 | 1.4 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
0.5 | 3.7 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.5 | 1.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.4 | 3.0 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.4 | 1.7 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.4 | 4.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.4 | 1.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.4 | 3.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.4 | 1.6 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.4 | 1.2 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
0.4 | 2.7 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.4 | 0.8 | GO:0051593 | response to folic acid(GO:0051593) receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.4 | 1.5 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.4 | 1.9 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.4 | 1.1 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.4 | 2.2 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.4 | 0.4 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.4 | 0.7 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.4 | 1.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.4 | 1.8 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.4 | 1.1 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.4 | 1.8 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.4 | 0.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.4 | 1.4 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.3 | 1.4 | GO:2001137 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) positive regulation of endocytic recycling(GO:2001137) |
0.3 | 2.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 0.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 2.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.3 | 1.3 | GO:0055071 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.3 | 2.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 1.0 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.3 | 2.3 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.3 | 6.5 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.3 | 2.9 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.3 | 3.8 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.3 | 0.9 | GO:0035844 | positive regulation of polarized epithelial cell differentiation(GO:0030862) cloaca development(GO:0035844) |
0.3 | 0.9 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.3 | 2.6 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.3 | 1.7 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.3 | 0.6 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.3 | 3.4 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.3 | 0.3 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
0.3 | 2.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 0.8 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.3 | 1.9 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.3 | 0.5 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.3 | 1.6 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.3 | 1.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 1.1 | GO:0061526 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.3 | 0.3 | GO:1905165 | regulation of lysosomal protein catabolic process(GO:1905165) |
0.3 | 0.3 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.3 | 1.3 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.3 | 1.6 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.3 | 3.6 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.3 | 3.6 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.3 | 0.5 | GO:0009405 | pathogenesis(GO:0009405) |
0.3 | 0.8 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.3 | 0.5 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
0.3 | 1.3 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.2 | 0.7 | GO:0021852 | pyramidal neuron migration(GO:0021852) |
0.2 | 1.5 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.2 | 1.0 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.2 | 1.0 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.2 | 1.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.2 | 4.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 1.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.2 | 1.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 0.9 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.2 | 1.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.9 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.2 | 19.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 0.7 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.2 | 2.3 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 6.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 2.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 1.5 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 5.5 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 1.5 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.2 | 0.9 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.2 | 1.5 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.2 | 2.8 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 2.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 1.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.2 | 0.6 | GO:0046959 | habituation(GO:0046959) |
0.2 | 0.6 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
0.2 | 1.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.2 | 0.8 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 4.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 1.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 0.4 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.2 | 1.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.2 | 0.8 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 2.2 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 1.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 0.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 1.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 0.4 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.2 | 1.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 2.9 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.2 | 0.4 | GO:0071649 | negative regulation of defense response to virus by host(GO:0050689) regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.2 | 0.6 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.2 | 1.0 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.2 | 0.6 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.2 | 0.6 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.2 | 3.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 4.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 0.6 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.2 | 0.7 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 1.7 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.2 | 2.0 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 1.1 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.2 | 2.5 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 1.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.7 | GO:0046543 | development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
0.2 | 1.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 0.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 0.3 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.2 | 0.8 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.2 | 0.7 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.8 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 1.0 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.2 | 0.5 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 0.7 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.2 | 1.0 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.2 | 0.8 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 0.5 | GO:0045004 | DNA replication proofreading(GO:0045004) |
0.2 | 1.8 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.2 | 0.9 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 0.3 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.3 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.6 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.1 | 0.6 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.1 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.1 | 3.9 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 0.6 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 1.9 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.6 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 2.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.7 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 1.9 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.1 | 0.7 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.1 | 0.5 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
0.1 | 0.5 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.1 | 1.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.1 | 0.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.5 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.4 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 3.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.5 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.1 | 2.9 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 0.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.4 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 1.6 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.2 | GO:0046878 | regulation of saliva secretion(GO:0046877) positive regulation of saliva secretion(GO:0046878) |
0.1 | 0.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.4 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 0.4 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.1 | 0.5 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
0.1 | 2.6 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.1 | 2.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 1.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 0.8 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.5 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.1 | 0.8 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.7 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 1.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 2.9 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 2.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.9 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.1 | 1.0 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.9 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.3 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 0.7 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.5 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.1 | 0.7 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.3 | GO:0048377 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) regulation of cardiac ventricle development(GO:1904412) positive regulation of cardiac ventricle development(GO:1904414) |
0.1 | 0.9 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.4 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.1 | 0.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 1.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.6 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.1 | 7.1 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 2.1 | GO:0001964 | startle response(GO:0001964) |
0.1 | 1.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 1.7 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.3 | GO:0010730 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.1 | 1.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 2.4 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 1.6 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.5 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 1.6 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 1.1 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 0.9 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 1.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 1.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.8 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 1.2 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 1.2 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.2 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 1.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.3 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.1 | 0.9 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 0.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.8 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.3 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 1.9 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 1.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.2 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.1 | 1.3 | GO:0043113 | receptor clustering(GO:0043113) |
0.1 | 0.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 1.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.2 | GO:2000561 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.1 | 0.6 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 0.2 | GO:0006101 | citrate metabolic process(GO:0006101) tricarboxylic acid metabolic process(GO:0072350) |
0.1 | 0.8 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 1.2 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.7 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 0.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.3 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.7 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.1 | 0.3 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.2 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.1 | 2.7 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) olfactory nerve development(GO:0021553) |
0.1 | 0.8 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 1.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 1.6 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.3 | GO:0090472 | dibasic protein processing(GO:0090472) |
0.1 | 0.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.1 | 1.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 1.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.2 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.1 | 0.9 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 0.6 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.7 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 1.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 1.4 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.1 | 0.1 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.1 | 0.2 | GO:0070602 | regulation of chondrocyte development(GO:0061181) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.1 | 0.4 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.1 | 0.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.6 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.1 | 0.7 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 1.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:0032916 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
0.1 | 0.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.3 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.1 | 0.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.3 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.4 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.4 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.3 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
0.1 | 0.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.9 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 0.4 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.8 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.1 | 0.4 | GO:0030431 | sleep(GO:0030431) |
0.1 | 0.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.5 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 0.4 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 0.3 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.9 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.8 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.1 | 0.4 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.6 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 1.5 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 1.2 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 2.3 | GO:0000045 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.1 | 1.0 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 1.6 | GO:0060078 | regulation of postsynaptic membrane potential(GO:0060078) |
0.1 | 0.4 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 1.0 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.1 | 0.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.5 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.1 | 0.6 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 0.1 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.0 | 0.9 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.0 | 2.8 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 1.5 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.6 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.0 | 0.7 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.0 | 0.0 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 2.1 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.0 | 0.1 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.0 | 0.5 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.2 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.0 | 0.2 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.0 | 0.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.0 | 0.6 | GO:0009651 | response to salt stress(GO:0009651) |
0.0 | 0.6 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.0 | 0.5 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.0 | 3.1 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.0 | 0.2 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.2 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.0 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.1 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.0 | 0.2 | GO:0015675 | nickel cation transport(GO:0015675) |
0.0 | 0.2 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.0 | 0.3 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.6 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 1.3 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.3 | GO:0097484 | dendrite extension(GO:0097484) |
0.0 | 0.4 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.6 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.0 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.7 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.8 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.0 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.0 | 0.7 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.0 | 1.6 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.2 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.4 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.0 | 0.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.4 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.0 | 0.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.1 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.0 | 0.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.3 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 1.8 | GO:0034333 | adherens junction assembly(GO:0034333) |
0.0 | 0.5 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.0 | 0.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.2 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.6 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 1.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.6 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.0 | 0.5 | GO:0048821 | erythrocyte development(GO:0048821) |
0.0 | 0.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.6 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 3.9 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.8 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.3 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 1.3 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.0 | 0.4 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
0.0 | 0.5 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.0 | 1.0 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.0 | 0.1 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 1.2 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 1.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 2.0 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.4 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.0 | 0.4 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.3 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.2 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.0 | 0.1 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.0 | 0.6 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.0 | 0.5 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.3 | GO:0010954 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.0 | 0.3 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.0 | 0.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.2 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.0 | 1.0 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.2 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.2 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 1.0 | GO:0016236 | macroautophagy(GO:0016236) |
0.0 | 0.6 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.7 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.0 | 0.1 | GO:0015879 | carnitine transport(GO:0015879) |
0.0 | 0.3 | GO:0007143 | female meiotic division(GO:0007143) |
0.0 | 1.1 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.0 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
0.0 | 0.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.9 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.0 | 0.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.0 | 0.3 | GO:0002209 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) fear response(GO:0042596) |
0.0 | 0.2 | GO:0010828 | positive regulation of glucose transport(GO:0010828) |
0.0 | 0.1 | GO:0090669 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) telomerase RNA stabilization(GO:0090669) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.8 | GO:0098855 | HCN channel complex(GO:0098855) |
0.9 | 2.8 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.8 | 2.5 | GO:0072534 | perineuronal net(GO:0072534) |
0.8 | 3.9 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.7 | 3.7 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.7 | 4.3 | GO:0097513 | myosin II filament(GO:0097513) |
0.7 | 3.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.7 | 2.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.6 | 0.6 | GO:0005683 | U7 snRNP(GO:0005683) |
0.6 | 1.9 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.6 | 0.6 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) endocytic vesicle membrane(GO:0030666) clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.5 | 2.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.5 | 2.1 | GO:0099569 | presynaptic cytoskeleton(GO:0099569) |
0.5 | 1.5 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.5 | 4.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.4 | 1.3 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.4 | 1.7 | GO:0031673 | H zone(GO:0031673) |
0.4 | 4.7 | GO:0000812 | Swr1 complex(GO:0000812) |
0.4 | 0.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 3.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.4 | 1.1 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.3 | 2.7 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.3 | 1.0 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.3 | 4.1 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.3 | 0.9 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.3 | 3.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.3 | 3.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.3 | 5.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 11.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.3 | 1.6 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.3 | 2.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 1.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.3 | 1.3 | GO:0032437 | cuticular plate(GO:0032437) |
0.3 | 8.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.3 | 1.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 2.0 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 1.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 6.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 2.3 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 3.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 1.6 | GO:0097433 | dense body(GO:0097433) |
0.2 | 1.8 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 1.2 | GO:0070847 | core mediator complex(GO:0070847) |
0.2 | 1.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 1.7 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.2 | 2.9 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 0.4 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
0.2 | 0.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 0.5 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.2 | 0.6 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 1.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.1 | 1.0 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 2.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.6 | GO:0043259 | laminin-1 complex(GO:0005606) laminin-10 complex(GO:0043259) |
0.1 | 2.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 3.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 1.4 | GO:0030677 | ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 1.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 1.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.3 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.1 | 1.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 5.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 1.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 3.0 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.9 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.6 | GO:0002177 | manchette(GO:0002177) |
0.1 | 1.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 5.6 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 2.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.1 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 4.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.1 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 1.4 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 4.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 1.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 1.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 3.6 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 1.0 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 4.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 1.8 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 1.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.6 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 1.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 29.1 | GO:0060076 | excitatory synapse(GO:0060076) |
0.1 | 0.5 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 22.7 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 1.1 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.6 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 5.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 12.0 | GO:0034702 | ion channel complex(GO:0034702) |
0.1 | 0.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.6 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 0.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 2.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 1.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.3 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 0.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 1.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 1.0 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 1.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 2.2 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.9 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.2 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 2.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 3.5 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 5.6 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.8 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.5 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.0 | 0.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.1 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.0 | 1.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 3.5 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 1.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 1.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.2 | GO:0070826 | paraferritin complex(GO:0070826) |
0.0 | 0.1 | GO:0034657 | GID complex(GO:0034657) |
0.0 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 1.4 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.3 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.8 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 6.2 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.3 | GO:0097342 | death-inducing signaling complex(GO:0031264) ripoptosome(GO:0097342) |
0.0 | 0.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.5 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.4 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 1.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 1.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.3 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.0 | 0.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.8 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.5 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 1.5 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.4 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 2.0 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 2.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.4 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 12.6 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 0.1 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
0.0 | 0.5 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 1.1 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.0 | 0.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 1.1 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 38.0 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.7 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.0 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.0 | 0.0 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.0 | 0.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.4 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.0 | 0.3 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.6 | GO:0005840 | ribosome(GO:0005840) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.2 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
1.5 | 4.5 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
1.4 | 5.8 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
1.4 | 4.1 | GO:0098770 | FBXO family protein binding(GO:0098770) |
1.3 | 7.7 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.0 | 3.0 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
1.0 | 2.9 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.9 | 4.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.9 | 7.1 | GO:0046790 | virion binding(GO:0046790) |
0.8 | 2.5 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.8 | 2.5 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.8 | 2.3 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.7 | 4.9 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.7 | 2.8 | GO:0038025 | reelin receptor activity(GO:0038025) |
0.7 | 2.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.7 | 3.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.7 | 2.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.6 | 3.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.6 | 1.9 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.6 | 3.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.6 | 1.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.6 | 3.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.6 | 3.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.6 | 1.8 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.6 | 2.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.5 | 3.8 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.5 | 2.1 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.5 | 1.5 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.5 | 3.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.5 | 5.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.5 | 3.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.5 | 1.8 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.5 | 4.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.5 | 1.4 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.4 | 2.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.4 | 2.2 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.4 | 4.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 0.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.4 | 2.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.4 | 1.2 | GO:0051379 | epinephrine binding(GO:0051379) |
0.4 | 10.5 | GO:0043274 | phospholipase binding(GO:0043274) |
0.4 | 1.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.4 | 3.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.4 | 5.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.4 | 3.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.4 | 5.8 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.4 | 1.8 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.4 | 2.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 1.1 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.4 | 1.8 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.4 | 1.8 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.4 | 1.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.4 | 3.9 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.4 | 3.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 1.7 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.3 | 2.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.3 | 1.3 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.3 | 1.9 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.3 | 1.0 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.3 | 6.6 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.3 | 5.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.3 | 1.2 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.3 | 1.2 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.3 | 1.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.3 | 5.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 4.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 4.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 0.9 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 1.1 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.3 | 2.6 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.3 | 1.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.3 | 1.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.3 | 1.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.3 | 0.8 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.2 | 2.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.2 | 1.0 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 1.2 | GO:0070330 | aromatase activity(GO:0070330) |
0.2 | 1.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 1.4 | GO:0097001 | ceramide binding(GO:0097001) |
0.2 | 0.7 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.2 | 0.9 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.2 | 0.7 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 2.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 3.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 0.4 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.2 | 0.6 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 0.8 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.2 | 2.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 1.6 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 1.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 1.5 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.2 | 3.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.8 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.2 | 0.2 | GO:0031208 | POZ domain binding(GO:0031208) |
0.2 | 2.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 4.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 0.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 2.6 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.2 | 0.9 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.2 | 0.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 0.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.7 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.2 | 1.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 1.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 1.6 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 0.2 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.2 | 0.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 0.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 5.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 0.3 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
0.2 | 1.9 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
0.2 | 0.5 | GO:0016361 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.2 | 0.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 2.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 1.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 3.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 5.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 2.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 0.5 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.2 | 2.3 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.2 | 0.6 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 0.8 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.2 | 0.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 0.9 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.6 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.8 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.1 | 0.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 1.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.7 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.6 | GO:0034041 | lipid-transporting ATPase activity(GO:0034040) sterol-transporting ATPase activity(GO:0034041) |
0.1 | 5.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 2.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 3.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.5 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 1.1 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 1.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 1.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 3.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.5 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.1 | 2.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.6 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 4.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 1.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 2.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 2.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 1.9 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.8 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.1 | 0.5 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 1.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 1.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 1.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 1.2 | GO:0019531 | secondary active sulfate transmembrane transporter activity(GO:0008271) oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 1.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 1.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 3.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.9 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.4 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.6 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.6 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.5 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 3.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 1.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 1.9 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 0.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 3.0 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 1.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 1.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.8 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.7 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.2 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.1 | 0.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 3.1 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 0.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 1.3 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.9 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.5 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 3.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 0.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.9 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.1 | 0.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 17.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.5 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.4 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.1 | 0.2 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.2 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 1.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 1.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.4 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.8 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 1.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.2 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.0 | 1.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.8 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.9 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 1.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 1.8 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 1.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 1.0 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 1.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 1.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 1.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 3.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 1.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.3 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 2.4 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.0 | 0.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 6.6 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 5.7 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.0 | 0.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 6.8 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 7.1 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.1 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.3 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 0.2 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.1 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
0.0 | 2.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.3 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 1.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.8 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.1 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.0 | 0.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.0 | 0.6 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.4 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.1 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 0.1 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 1.7 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.0 | 0.5 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.2 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.6 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 2.1 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.0 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.1 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.6 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | ST_PAC1_RECEPTOR_PATHWAY | PAC1 Receptor Pathway |
0.4 | 6.8 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
0.4 | 8.1 | ST_WNT_CA2_CYCLIC_GMP_PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 1.2 | ST_IL_13_PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 2.4 | PID_ALK2_PATHWAY | ALK2 signaling events |
0.2 | 0.9 | SIG_IL4RECEPTOR_IN_B_LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 1.1 | PID_EPHA2_FWD_PATHWAY | EPHA2 forward signaling |
0.2 | 5.2 | ST_GRANULE_CELL_SURVIVAL_PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 3.6 | PID_IL2_STAT5_PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 4.7 | PID_MYC_PATHWAY | C-MYC pathway |
0.1 | 1.2 | PID_INTEGRIN4_PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.9 | PID_TCR_RAS_PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 5.0 | PID_IL2_1PATHWAY | IL2-mediated signaling events |
0.1 | 6.8 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
0.1 | 0.8 | PID_S1P_S1P4_PATHWAY | S1P4 pathway |
0.1 | 2.0 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 5.0 | PID_ARF6_PATHWAY | Arf6 signaling events |
0.1 | 3.0 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
0.1 | 2.6 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
0.1 | 1.7 | PID_ERBB_NETWORK_PATHWAY | ErbB receptor signaling network |
0.1 | 1.0 | SA_MMP_CYTOKINE_CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 5.8 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
0.1 | 2.9 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 6.7 | PID_SHP2_PATHWAY | SHP2 signaling |
0.1 | 0.5 | SA_PTEN_PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 2.1 | PID_CD40_PATHWAY | CD40/CD40L signaling |
0.1 | 4.3 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 1.8 | PID_IFNG_PATHWAY | IFN-gamma pathway |
0.1 | 6.6 | PID_LKB1_PATHWAY | LKB1 signaling events |
0.1 | 7.1 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 3.8 | PID_PI3KCI_AKT_PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 2.3 | PID_ARF_3PATHWAY | Arf1 pathway |
0.1 | 1.9 | PID_CIRCADIAN_PATHWAY | Circadian rhythm pathway |
0.1 | 0.3 | ST_ADRENERGIC | Adrenergic Pathway |
0.1 | 1.0 | PID_S1P_META_PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 9.8 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 3.0 | PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.8 | PID_AR_NONGENOMIC_PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.7 | ST_JNK_MAPK_PATHWAY | JNK MAPK Pathway |
0.1 | 2.2 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 1.2 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.9 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
0.1 | 0.9 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
0.1 | 1.2 | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.4 | PID_ERBB4_PATHWAY | ErbB4 signaling events |
0.1 | 2.4 | PID_ARF6_TRAFFICKING_PATHWAY | Arf6 trafficking events |
0.1 | 2.1 | PID_NFAT_TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.8 | PID_PS1_PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 2.8 | PID_P53_REGULATION_PATHWAY | p53 pathway |
0.0 | 0.5 | PID_IL2_PI3K_PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.7 | PID_LYSOPHOSPHOLIPID_PATHWAY | LPA receptor mediated events |
0.0 | 0.8 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.5 | ST_G_ALPHA_I_PATHWAY | G alpha i Pathway |
0.0 | 0.3 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
0.0 | 0.7 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
0.0 | 0.8 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.7 | ST_TUMOR_NECROSIS_FACTOR_PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 1.1 | PID_TNF_PATHWAY | TNF receptor signaling pathway |
0.0 | 0.6 | PID_PI3KCI_PATHWAY | Class I PI3K signaling events |
0.0 | 0.6 | PID_RAS_PATHWAY | Regulation of Ras family activation |
0.0 | 0.9 | PID_CD8_TCR_PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.4 | SIG_BCR_SIGNALING_PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.2 | PID_WNT_NONCANONICAL_PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.3 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
0.0 | 1.4 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
0.0 | 0.8 | PID_ECADHERIN_STABILIZATION_PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.2 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.4 | PID_MET_PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.5 | PID_FAK_PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.2 | ST_MYOCYTE_AD_PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.5 | PID_RHOA_PATHWAY | RhoA signaling pathway |
0.0 | 0.2 | PID_RETINOIC_ACID_PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.2 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.5 | PID_REG_GR_PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.3 | PID_IL12_2PATHWAY | IL12-mediated signaling events |
0.0 | 0.3 | PID_KIT_PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.6 | PID_RHOA_REG_PATHWAY | Regulation of RhoA activity |
0.0 | 0.3 | PID_ERBB1_DOWNSTREAM_PATHWAY | ErbB1 downstream signaling |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | REACTOME_SIGNAL_AMPLIFICATION | Genes involved in Signal amplification |
0.5 | 5.5 | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.4 | 3.0 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 1.1 | REACTOME_SEROTONIN_RECEPTORS | Genes involved in Serotonin receptors |
0.4 | 3.2 | REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 4.5 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 3.3 | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.3 | 10.3 | REACTOME_SYNTHESIS_OF_PA | Genes involved in Synthesis of PA |
0.3 | 8.3 | REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.3 | 3.1 | REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 4.0 | REACTOME_DSCAM_INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 4.5 | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | Genes involved in Degradation of the extracellular matrix |
0.3 | 3.9 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 9.8 | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.3 | 10.6 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 1.7 | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 8.7 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 3.6 | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 2.8 | REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 4.4 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 2.7 | REACTOME_PLATELET_SENSITIZATION_BY_LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 7.5 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 1.7 | REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 3.2 | REACTOME_LIGAND_GATED_ION_CHANNEL_TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 5.9 | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 1.9 | REACTOME_IRON_UPTAKE_AND_TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 6.1 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
0.2 | 0.9 | REACTOME_IL_7_SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.7 | REACTOME_G_ALPHA1213_SIGNALLING_EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 2.5 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 2.2 | REACTOME_NEPHRIN_INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 3.2 | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 4.1 | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 3.8 | REACTOME_REGULATORY_RNA_PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 6.1 | REACTOME_PI3K_AKT_ACTIVATION | Genes involved in PI3K/AKT activation |
0.1 | 3.8 | REACTOME_RAP1_SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.5 | REACTOME_DOWNSTREAM_TCR_SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 2.6 | REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.6 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.6 | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 1.5 | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 4.5 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
0.1 | 1.0 | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.8 | REACTOME_P38MAPK_EVENTS | Genes involved in p38MAPK events |
0.1 | 1.6 | REACTOME_GAP_JUNCTION_DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 3.5 | REACTOME_EGFR_DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 3.0 | REACTOME_NETRIN1_SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.7 | REACTOME_THE_NLRP3_INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.2 | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.6 | REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.1 | 1.3 | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 2.5 | REACTOME_METAL_ION_SLC_TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 2.2 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 4.7 | REACTOME_POTASSIUM_CHANNELS | Genes involved in Potassium Channels |
0.1 | 2.1 | REACTOME_SULFUR_AMINO_ACID_METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 0.7 | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 2.1 | REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 2.8 | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 1.4 | REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.4 | REACTOME_ERK_MAPK_TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 1.0 | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 2.0 | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 2.3 | REACTOME_ION_CHANNEL_TRANSPORT | Genes involved in Ion channel transport |
0.1 | 1.5 | REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 1.1 | REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.7 | REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 3.9 | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.9 | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 3.4 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 1.6 | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.4 | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.8 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 1.1 | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.4 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.9 | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.3 | REACTOME_NUCLEAR_SIGNALING_BY_ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 0.3 | REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.3 | REACTOME_REGULATION_OF_KIT_SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 1.5 | REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 1.0 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 1.2 | REACTOME_GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.4 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 1.5 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.0 | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.5 | REACTOME_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POL_IN_TC_NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.0 | 0.8 | REACTOME_IL1_SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.5 | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.2 | REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 1.1 | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.2 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.5 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.6 | REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.1 | REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.5 | REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.1 | REACTOME_TIE2_SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.3 | REACTOME_SIGNALING_BY_EGFR_IN_CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.2 | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.2 | REACTOME_PERK_REGULATED_GENE_EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 1.6 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.4 | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.2 | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.3 | REACTOME_MRNA_3_END_PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 0.1 | REACTOME_CS_DS_DEGRADATION | Genes involved in CS/DS degradation |